2026 ASTRO Annual Meeting

Location: Boston, Massachusetts | Menino Convention and Exhibition Center

Date: September 26–30, 2026

Technologies:

At a glance

This event has passed.

Featured Presentation

Genomic Stratification of Benefit from Short-Term Androgen Deprivation with Dose-Escalated Radiotherapy in Intermediate-Risk Prostate Cancer: An Ancillary Study of RTOG/NRG 0815.

Tuesday, September 29th | 3:55pm – 4:05pm ET
Oral | Abstract #312 – Room 210

Angela Jia, M.D., Ph.D.

All GU Oncology Presentations & Posters

Title	Session	Abstract	Date	Time	Author(s) / Speakers	Location	Schedule
Evaluation of PAM50 Molecular Subtypes in Post-Prostatectomy Salvage Radiotherapy: An NRG Oncology-RTOG 0534 Analysis	Oral	Abstract #6	Sunday, September 27	1:30 – 1:40 PM ET	Shuang Zhao, M.D., M.S.E.	Grand Ballroom	View
The Role of Docetaxel In Addition to Salvage Radiation and Androgen Deprivation In Men with High Risk Prostate Cancer Post-Prostatectomy: Results of NRG GU002	Oral	Abstract #250	Tuesday, September 29	12:40 – 12:50 PM ET	Mark Hurwitz, M.D., FASTRO	Room 210	View
Preoperative Biopsy Decipher Prostate Genomic Classifier Predicts Earlier Secondary Radiotherapy After Radical Prostatectomy in National Real-World Data	Poster	Abstract #3297	Tuesday, September 29	2:15 – 3:30 PM ET	Thomas Kole, M.D., Ph.D.	Poster Hall – Exhibit Hall A	View
Association of 22-Gene Genomic Classifier with ADT Use with Secondary Radiotherapy: A National Real-World Analysis	Poster	Abstract #3226	Tuesday, September 29	2:15 – 3:30 PM ET	Andrew Barsky, M.D.	Poster Hall – Exhibit Hall A	View
Genomic Stratification of Benefit from Short-Term Androgen Deprivation with Dose-Escalated Radiotherapy in Intermediate-Risk Prostate Cancer: An Ancillary Study of RTOG/NRG 0815	Oral	Abstract #312	Tuesday, September 29	3:55 – 4:05 PM ET	Angela Jia, M.D., Ph.D.	Room 210	View
Multi-institutional Transcriptomic Characterization of Radiorecurrent Prostate Cancer and Prognostic Biomarkers After Salvage Re-irradiation in the F-SHARP Clinical Trial	Oral	Abstract #314	Tuesday, September 29	4:15 – 4:25 PM ET	Abhishek Solanki, M.D., M.S.	Room 210	View
Long-Term Transcriptomic Analysis of NRG/RTOG 9601: A Phase 3 Study of Salvage Radiotherapy for Prostate Cancer with or without Anti-Androgen Therapy	Oral	Abstract #315	Tuesday, September 29	4:25 – 4:35 PM ET	Krishnan Patel, M.D.	Room 210	View
Real-World Evidence across Prostate RT Modalities: Utilization Shifts, Toxicity and BCR in Genomic Classifier Scored Patients	Quick Pitch	Abstract #1166	Tuesday, September 29	5:35 – 5:40 PM ET	Thomas Kole, M.D., Ph.D.	Room 205	Vie w

Meet with us

Interested in connecting with our team at this event? We’d love to hear from you.

2026 ASTRO Annual Meeting

At a glance

Meet with us

Tags

Keep exploring

Veracyte Diagnostics Platform

Clinical Studies

Scientific Publications

Press Releases